Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04203147 · ClinicalTrials.gov registry record · NA

Home-based Diabetes-Modified Behavioral Activation Treatment for Low Income Seniors With T2DM

A NA study, sponsored by State University of New York at Buffalo.

Completed
Registry status
NA
Development phase
200
Enrollment target

NCT04203147 is a NA study that has completed, run by State University of New York at Buffalo. The registered enrollment target is 200 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04203147, a NA study, has completed, sponsored by State University of New York at Buffalo.

COMPLETED
Registry status
NA
Development phase
200 participants
Enrollment target

Study Summary

The objective of this protocol is to evaluate the efficacy and cost-effectiveness of 8 sessions of in-home, telephone-delivered, culturally-modified, manualized diabetes-modified, behavioral activation treatment (Home DM-BAT) delivered by trained diabetes nurse educators among low income, ethnic minority seniors with poorly controlled T2DM. The aims of this randomized controlled efficacy trial are: Aim: To test the efficacy of Home DM-BAT on glycemic control (hemoglobin A1c). Hypothesis: Low income, minority seniors with poorly controlled T2DM randomized to Home DM-BAT will have significantly greater improvements in glycemic control (hemoglobin A1c) at 12 months of follow-up compared to the control group (in-home, telephone-delivered supportive therapy - ST).

Interventions

  • BEHAVIORAL Supportive Therapy (Control)
  • BEHAVIORAL Home DM-BAT

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2020-01-03
Est. Completion 2026-01-01
Phase NA

What the Registry Record Tells You About NCT04203147

The ClinicalTrials.gov registry entry for NCT04203147 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is State University of New York at Buffalo, which has 243 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Supportive Therapy (Control) is the first listed.

NCT04203147 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04203147 about?

NCT04203147 is a clinical study titled "Home-based Diabetes-Modified Behavioral Activation Treatment for Low Income Seniors With T2DM". The objective of this protocol is to evaluate the efficacy and cost-effectiveness of 8 sessions of in-home, telephone-delivered, culturally-modified, manualized diabetes-modified, behavioral activation treatment (Home DM-BAT) delivered by trained diabetes nurse educators among low income, ethnic min...

What is the current status of trial NCT04203147?

This trial is currently completed. It is a NA study. The enrollment target is 200 participants. The study started on 2020-01-03. Estimated completion is 2026-01-01.

What interventions are being tested in trial NCT04203147?

The interventions under investigation include: Supportive Therapy (Control) (BEHAVIORAL), Home DM-BAT (BEHAVIORAL).

Who is sponsoring clinical trial NCT04203147?

This trial is sponsored by State University of New York at Buffalo, which has 243 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.